Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Avenue Therapeutics ( (ATXI) ) is now available.
Avenue Therapeutics, Inc. has awarded equity incentives to key executives under its 2015 Incentive Plan. CEO Alexandra MacLean received 170,000 restricted stock units (RSUs), while Interim CFO and COO David Jin was granted 65,000 RSUs. These awards vest over four installments on specified dates from 2024 to 2026, contingent on continued service to the company. The RSUs will be settled either upon the employee’s departure under specific conditions or during a change in company control.
See more insights into ATXI stock on TipRanks’ Stock Analysis page.